FDA approves Teva leukemia drug 
October 26th, 2012
Fri Oct 26, 2012 11:51am EDT (Reuters) – The U.S.
[Continue Reading...]
Are cancer patients’ hopes for chemo too high?
October 24th, 2012
By Gene Emery NEW YORK | Wed Oct 24, 2012 5:07pm EDT NEW YORK (Reuters Health) – At least two thirds of people with advanced cancer in a new survey believed the chemotherapy they’re receiving might cure them, even though the treatment is only being given to buy some time or make them comfortable. “Their expectations are way out of line with reality,” Dr. Deborah Schrag of the Dana-Farber Cancer Institute in Boston told Reuters Health.
[Continue Reading...]
Serious birth complications rising in the U.S
October 23rd, 2012
By Amy Norton NEW YORK | Tue Oct 23, 2012 3:12pm EDT NEW YORK (Reuters Health) – Severe complications from childbirth are rare in the U.S., but they are becoming more common, a new government study finds.
[Continue Reading...]
Study finds why Roche’s Avastin only works in some patients
October 23rd, 2012
By Kate Kelland LONDON | Tue Oct 23, 2012 1:01pm EDT LONDON (Reuters) – Genetic testing could help doctors find the small number of patients with advanced bowel cancer likely to benefit from cancer drug Avastin, scientists said on Tuesday. In a study of Roche’s blockbuster drug, which targets and blocks a protein called VEGF-A, researchers found that different forms of the protein lead to varying responses and Avastin had no benefit in at least half of those taking it
[Continue Reading...]
Orexigen says FDA may allow faster resubmission for diet pill
October 22nd, 2012
Mon Oct 22, 2012 8:01am EDT (Reuters) – Orexigen Inc said the U.S. health regulator indicated it would be willing to discuss a faster resubmission of the company’s application to market its weight loss pill Contrave. The U.S
[Continue Reading...]
Extra pounds tied to higher risk of hospitalization
October 19th, 2012
By Genevra Pittman NEW YORK | Fri Oct 19, 2012 4:44pm EDT NEW YORK (Reuters Health) – Regardless of lifestyle and other health-related factors, heavier people were more likely than lean ones to be hospitalized for a variety of conditions in a new study from Australia. That was the case not just for obese people, but for the merely overweight as well.
[Continue Reading...]
Italy court ruling links mobile phone use to tumor
October 19th, 2012
ROME | Fri Oct 19, 2012 11:18am EDT ROME (Reuters) – Italy’s supreme court has upheld a ruling that said there was a link between a business executive’s brain tumor and his heavy mobile phone usage, potentially opening the door to further legal claims. The court’s decision flies in the face of much scientific opinion, which generally says there is not enough evidence to declare a link between mobile phone use and diseases such as cancer and some experts said the Italian ruling should not be used to draw wider conclusions about the subject.
[Continue Reading...]
U.S. FDA panel backs Sanofi, Isis drug for rare disorder
October 18th, 2012
By David Morgan WASHINGTON | Thu Oct 18, 2012 4:29pm EDT WASHINGTON (Reuters) – A U.S. Food and Drug Administration panel of outside experts recommended the Sanofi SA and Isis Pharmaceutical Inc drug, Kynamro, for treatment of a rare genetic disorder that causes unusually high cholesterol and life-threatening cardiovascular disease. In a 9-6 vote on Thursday, the FDA advisory committee concluded that company-provided research showed the 200 milligram injection to be safe and effective enough for the one in 1 million Americans who have homozygous familial hypercholesterolemia, or HoFH, and are already on a cholesterol treatment regimen that includes lipid-lowering medication.
[Continue Reading...]
Americans’ heart devices reused safely in India
October 15th, 2012
By Amy Norton NEW YORK | Mon Oct 15, 2012 6:16pm EDT NEW YORK (Reuters Health) – U.S. patients’ used heart devices can be safely implanted in seriously ill heart disease patients in the developing world, a study out Monday suggests.
[Continue Reading...]
Kids with ADHD have dimmer prospects: study
October 15th, 2012
By Frederik Joelving NEW YORK | Mon Oct 15, 2012 4:55pm EDT NEW YORK (Reuters Health) – Children with ADHD symptoms tend to fare worse as adults than do kids without problems in school, according to the longest follow-up study of the disorder to date. They have less education and lower income, on average, and higher rates of divorce and substance abuse, according to findings released today in the Archives of General Psychiatry.
[Continue Reading...]
